Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M794Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M794EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with PBE

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PBE is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PBE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CONDON PHILIP GPortfolio Manager 2013-11-26Buy3,000$11.75286.98 view
GABELLI MARIO JControl Person of Adviser 2013-11-26Sell35,600$21.47111.78 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$15.76188.52 view
FRIEDRICH ROMAN IIITrustee 2013-11-25Buy100$21.48111.69 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy130$18.19149.97 view
Jackson Deborah CTrustee of the Fund 2013-11-25Buy135$17.8155.45 view
CONDON PHILIP GPortfolio Manager 2013-11-22Buy8,500$11.8285.34 view
Dammeyer Rodney FDirector 2013-11-22Buy31,940$6.16638.15 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy107$18.06151.77 view
BURGESS PETER STrustee of the Fund 2013-11-22Buy113$18.09151.35 view

Press Releases about PBE :

    Quarterly/Annual Reports about PBE:

      News about PBE:

      Articles On GuruFocus.com
      No related article found.


      More From Other Websites
      Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? Sep 09 2014
      Interesting Biotech ETF Additions on the Way Sep 05 2014
      Biotech ETFs Look to Build on Hot August Returns Sep 03 2014
      Biotechnology ETFs Show Robust Health In August Sep 02 2014
      Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN) Aug 27 2014
      After Recent Surge, Are Biotech ETFs Back on Track? Aug 26 2014
      Biotech ETFs Surge on InterMune-Roche Deal Aug 26 2014
      InterMune Acquisition Could Ignite These Biotech ETFs Aug 25 2014
      4 Biotech ETFs Beating S&P 500 Jul 29 2014
      The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Market Vectors Biotech ETF, iShares... Jun 26 2014
      Biotech ETF Nears a Critical Juncture Jun 25 2014
      Vertex Pharma Pushes Biotech ETFs Higher Jun 25 2014
      Vertex Lifts These Biotech ETFs Jun 24 2014
      How Will Biotechnology ETFs Finish Out the Year? Jun 18 2014
      Most Searched ETFs: Surging Sectors Jun 14 2014
      Buyout Cycle Boosts Biotech ETFs Jun 13 2014
      Biotech ETFs Bounce Back After Three-Month Correction Jun 11 2014
      Two Biotech ETFs Surge on Idenix-Merck Deal Jun 10 2014
      Why These Two Biotech ETFs Are Soaring Monday Jun 09 2014
      A Comprehensive Guide to Biotech ETFs May 29 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK